Key result
MCT-rich formula resolves lipemia retinalis and sharply improves lipids in infant with PCSK9 variant.
Why the study?
Does a specialized MCT-rich formula diet improve lipemia retinalis and lipid profile in an infant with severe hypertriglyceridemia and a PCSK9 variant?
Population
A 36-day-old male infant with lipemia retinalis and a heterozygous PCSK9 mutation
Design
Case report
Follow-up
One-month
Authors
Loading...
May support MCT formula in rare infantile hyperlipidemia; hypothesis-generating and requires prospective trials before practice change.
Case Report (n=1)
No
Does a specialized MCT-rich formula diet improve lipemia retinalis and lipid profile in an infant with severe hypertriglyceridemia and a PCSK9 variant?
Lipemia retinalis in an infant with severe hypertriglyceridemia and a PCSK9 variant resolved completely following transition to an MCT-rich formula diet, highlighting the importance of early recognition and dietary management of complex pediatric dyslipidemia.
Ismail et al. (2026) conducted a case report in Lipemia retinalis and severe hypertriglyceridemia (n=1). Specialized medium-chain triglyceride (MCT)-rich formula diet was evaluated on Resolution of lipemia retinalis and lipid profile improvement. Transition to a specialized medium-chain triglyceride-rich formula led to complete resolution of lipemia retinalis and marked improvement in lipid levels in an infant with a PCSK9 variant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: